| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |